RE:Aphria Management is smarter than any other on the market!And lets not forget the unnamed privately owned company partnership with Tetra Bio Pharma...which IMO I think is Apotex.
Remember this article..
Tetra Bio-Pharma to engage in co-development and distribution partnership with major healthcare specialty distributor
This privately-owned partner, which asked to remain unnamed for the time being, has a pan-Canadian distribution network that reaches up to 7000 specialized healthcare professionals. Through their distribution channel, they have access to over 3000 specialized healthcare businesses in Canada and already work with a worldwide network of partners, including the USA. https://www.marketwired.com/press-release/tetra-bio-pharma-engage-co-development-distribution-partnership-with-major-healthcare-tsx-venture-tbp-2234360.htm Apotex Inc. was founded in 1974, and is the largest Canadian-owned pharmaceutical company. From its 2 employees, 5,000 square foot beginning, the company has grown to employ over 10,000 people in research, development, manufacturing and distribution facilities world-wide. The Canadian operations of the Apotex Group of Companies has over 6,000 employees. Extensive investments in Canadian facilities include over 3 million square feet in manufacturing and R&D facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. Apotex produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats which, in Canada, are used to fill over 89 million prescriptions a year - the largest amount of any pharmaceutical company in this country.
Today, Apotex is a necessary and trusted member of Canada's healthcare community. The company's pharmaceuticals can be found in virtually every pharmacy and healthcare facility in Canada and are exported to over 115 countries around the globe. Export markets represent an ever growing portion of the total sales. Apotex has also established a presence through subsidiaries, joint ventures or licensing agreements in Australia, Belgium, Czech Republic, Mexico, Netherlands, New Zealand and Poland to name just a few. Healthcare professionals around the world rely on Apotex for quality and value.
Although the company's own business is developing and manufacturing generic pharmaceuticals, the success of Apotex has enabled it to diversify into a number of other health-related areas. The Apotex Pharmaceutical Group of Companies also researches, develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, and disposable plastics for medical use.
The worldwide sales of the Apotex Group of companies exceed $2 billion (Canadian $) per year.
sunny3999 wrote: Aphria is targeting the Pharma Industry the markup or say premium will huge, imagine a 5 bn pain market with Tetra Biopharm. Nuuvera with Avantix and Avalon Rx and Scientus Pharma lets get this companies get FDA/HC Phase 3 appoved medical products.
Aphria will need ear muffs to overhear the loud knocking at the door!
Then there is still the Rec Market, Aphria is playing it safe from not giving the Royal Flush out of the hand for a discount.....
